Why the study?
Fluoroquinolone administration can lead to corrected QT prolongation, but information on its incidence and risk factors in critically ill patients is lacking.
Answers are grounded in this paper and cite their sources.
Background : Despite the high bioavailability and broad-spectrum activity of fluoroquinolones (FQs), their administration can lead to corrected QT prolongation. However, there is a lack of information on the incidence and risk factors for FQ-induced long QT in critically ill patients. Our objective is to determine the incidence of QT prolongation and identify the associated risk factors under real-time 24 hour monitoring.
No takes yet. Share an insight, caveat, or question.
Choi et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: